Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells

被引:106
作者
Häcker, H
Mischak, H
Häcker, G
Eser, S
Prenzel, N
Ullrich, A
Wagner, H
机构
[1] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany
[2] Med Hsch Hannover, Dept Nephrol, D-30625 Hannover, Germany
[3] Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany
关键词
CpG-DNA; IL-12; innate immunity; MAP kinase; TNF;
D O I
10.1093/emboj/18.24.6973
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of antigen-presenting cells (APCs) by invariant constituents of pathogens such as lipopolysaccharide (LPS) or bacterial DNA (CpG-DNA) initiates immune responses. We have analyzed the mitogen-activated protein kinase (MAPK) pathways triggered by CpG-DNA and their significance for cytokine production in two subsets of APCs, i.e. macrophages and dendritic cells (DCs). We found that CpG-DNA induced extracellular signal-regulated kinase (ERK) activity in macrophages in a classic MEK-dependent way. This pathway up-regulated tumor necrosis factor production but down-regulated interleukin (IL)-12 production. However, in DCs, which produce large amounts of IL-12, CpG-DNA and LPS failed to induce ERK activity. Consistent with a specific negative regulatory role for ERK in macrophages, chemical activation of this pathway in DCs suppressed CpG-DNA-induced IL-12 production. Overall, these results imply that differential activation of MAP kinase pathways is a basic mechanism by which distinct subsets of innate immune cells regulate their effector functions.
引用
收藏
页码:6973 / 6982
页数:10
相关论文
共 62 条
[41]  
PRICHETT W, 1995, J INFLAMM, V45, P97
[42]   Relative contribution of transcription and translation to the induction of tumor necrosis factor-α by lipopolysaccharide [J].
Raabe, T ;
Bukrinsky, M ;
Currie, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (02) :974-980
[43]   Dendritic cell survival and maturation are regulated by different signaling pathways [J].
Rescigno, M ;
Martino, M ;
Sutherland, CL ;
Gold, MR ;
Ricciardi-Castagnoli, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2175-2180
[44]  
Sanghera JS, 1996, J IMMUNOL, V156, P4457
[45]   ACTIVATED T-CELLS INDUCED INTERLEUKIN-12 PRODUCTION BY MONOCYTES VIA CD40-CD40 LIGAND INTERACTION [J].
SHU, U ;
KINIWA, M ;
WU, CY ;
MALISZEWSKI, C ;
VEZZIO, N ;
HAKIMI, J ;
GATELY, M ;
DELESPESSE, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (04) :1125-1128
[46]   FLT3: Receptor and ligand. Biology and potential clinical application [J].
Shurin, MR ;
Esche, C ;
Lotze, MT .
CYTOKINE & GROWTH FACTOR REVIEWS, 1998, 9 (01) :37-48
[47]   T-cell-independent granuloma formation in response to Mycobacterium avium:: role of tumour necrosis factor-α and interferon-γ [J].
Smith, D ;
Hänsch, H ;
Bancroft, G ;
Ehlers, S .
IMMUNOLOGY, 1997, 92 (04) :413-421
[48]   In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas [J].
Sousa, CRE ;
Hieny, S ;
SchartonKersten, T ;
Jankovic, D ;
Charest, H ;
Germain, RN ;
Sher, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) :1819-1829
[49]  
Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO
[50]  
2-8